Abstract
We suggest a mathematical model for the spread of an infectious disease in human population, with particular attention to the COVID-19. Common epidemiological models, e.g., the well-known susceptible-exposed-infectious-recovered (SEIR) model, implicitly assume fast mixing of the population relative to the local infection rate, similar to the regime applicable to many chemical reactions. However, in human populations, especially under different levels of quarantine conditions, this assumption is likely to fail. We develop a continuous spatial model that includes five different populations, in which the infectious population is split into latent (or pre-symptomatic) and symptomatic. Based on nearest-neighbor infection kinetics, we arrive into a “reaction-diffusion” model. Our model accounts for front propagation of the infectious population domains under partial quarantine conditions, which is present on top of the common local infection process. Importantly, we also account for the variable geographic density of the population, that can strongly enhance or suppress infection spreading. Our results demonstrate how infected domains spread outward from epicenters/hotspots, leading to different regimes of sub-exponential (quasi linear or power-law) growth. Moreover, we show how weakly infected regions surrounding a densely populated area can cause rapid migration of the infection towards the center of the populated area. Predicted heat-maps show remarkable similarity to recently media released heat-maps. We further demonstrate how localized strong quarantine conditions can prevent the spreading of the disease from an epicenter/hotspot, significantly reducing the number of infected people. Application of our model in different countries, using actual demographic data and infectious disease parameters, can provide a useful predictive tool for the authorities, in particular, for planning strong lockdown measures in localizes areas.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
YT Acknowledges support by the Israel Science Foundation Grant No. 274/19.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Theoretical modeling - do not require approval of ethics committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data may be provided upon request by e-mail.
